Population Prevalence, Incidence, and Predictors of Atrial Fibrillation in the Renfrew/Paisley Study
Overview
Authors
Affiliations
Objectives: Though atrial fibrillation (AF) is an important cause of cardiovascular morbidity, there are few large epidemiological studies of its prevalence, incidence, and risk factors. The epidemiological features of AF are described in one of the largest population cohorts ever studied.
Methods: The prevalence and incidence of AF were studied in the Renfrew/Paisley population cohort of 15 406 men and women aged 45-64 years living in the west of Scotland. This cohort was initially screened between 1972 and 1976 and again between 1977 and 1979. Incident hospitalisations with AF in the 20 year period following initial screening were also studied.
Results: The population prevalence of AF in this cohort was 6.5 cases/1000 examinations. Prevalence was higher in men and older subjects. In those who were rescreened, the four year incidence of AF was 0.54 cases/1000 person years. Radiological cardiomegaly was the most powerful predictor of new AF (adjusted odds ratio 14.0). During 20 year follow up, 3.5% of this cohort was discharged from hospital with a diagnosis of AF; the rate of incident hospitalisation for AF was 1.9 cases/1000 person years. Radiological cardiomegaly (adjusted odds ratio 1.46) and systolic blood pressure (adjusted odds ratio 2.1 for >/= 169 mm Hg) were independent predictors of this outcome.
Conclusions: Data from one of the largest epidemiological studies ever undertaken confirm that AF has a large population prevalence and incidence, even in middle aged people. More important, it was shown that the long term incidence of hospitalisation related to AF is high and that two simple clinical measurements are highly predictive of incident AF. These findings have important implications for the prevention of AF.
Anabolic steroids as the substrate for atrial fibrillation: a case report.
Yebari M, Bouchaala A, Berraj I Eur Heart J Case Rep. 2024; 8(11):ytae585.
PMID: 39545154 PMC: 11561561. DOI: 10.1093/ehjcr/ytae585.
Daoudi S, John K, Chalhoub F, Chee J, Infeld M, Elbaz-Greener G J Clin Med. 2024; 13(16).
PMID: 39201025 PMC: 11355455. DOI: 10.3390/jcm13164883.
Atrial Fibrillation and Chronic Kidney Disease: Aetiology and Management.
Sidhu B, Mavilakandy A, Hull K, Koev I, Vali Z, Burton J Rev Cardiovasc Med. 2024; 25(4):143.
PMID: 39076563 PMC: 11264032. DOI: 10.31083/j.rcm2504143.
Cizauskas H, Burnham H, Panni A, Pena A, Alvarez-Arce A, Davis M Am J Physiol Heart Circ Physiol. 2024; 327(2):H460-H472.
PMID: 38940916 PMC: 11442024. DOI: 10.1152/ajpheart.00148.2024.
Fine tuning contractility: atrial sarcomere function in health and disease.
Burnham H, Cizauskas H, Barefield D Am J Physiol Heart Circ Physiol. 2023; 326(3):H568-H583.
PMID: 38156887 PMC: 11221815. DOI: 10.1152/ajpheart.00252.2023.